Lin Zhu
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 8
-
- Radiopharmaceutical Chemistry and Applications 35
- Medical Imaging Techniques and Applications 34
- Materials Chemistry top 5%
- Pharmaceutical Science top 5%
-
- Cancer, Hypoxia, and Metabolism 14
-
- Prostate Cancer Treatment and Research 13
- Medical Imaging and Pathology Studies 10
-
- Peptidase Inhibition and Analysis 12
-
- Neuroscience and Neuropharmacology Research 9
- Co-authors
- Hank F. KungXiaoshan ZhuKarl PlöesslShengyan TianYongsheng ChenZhenghua DuanYan LiZhihao Zha
- Journals
- Science (1 paper)Journal of the American Chemical Society (1 paper)Chemical Society Reviews (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lin Zhu
130 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 142
- Biochemistry 175
- Radiology, Nuclear Medicine and Imaging 499
- Health, Toxicology and Mutagenesis 285
- Materials Chemistry 806
- Pharmaceutical Science 101
Countries citing papers authored by Lin Zhu
This map shows the geographic impact of Lin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhu more than expected).
Fields of papers citing papers by Lin Zhu
This network shows the impact of papers produced by Lin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhu. The network helps show where Lin Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | Naringin Inhibits the Proliferation, Migration, Invasion and Epithelial-to-Mesenchymal Transition of Gastric Cancer Cells via the PI3K/AKT Signaling Pathway. | 2023 | 5 |
| 7 | 2023 | 4 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 42 | |
| 11 | 2021 | 9 | |
| 12 | 2019 | 81 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 19 | |
| 16 | 2013 | 6 | |
| 17 | 2013 | 14 | |
| 18 | 2012 | 3 | |
| 19 | 2010 | 19 | |
| 20 | 2008 | 9 |
About Lin Zhu
Lin Zhu is a scholar working on Radiology, Nuclear Medicine and Imaging, Biochemistry and Cancer Research, having authored 141 papers that have together received 2.4k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (35 papers), Medical Imaging Techniques and Applications (34 papers), Cancer, Hypoxia, and Metabolism (14 papers), Prostate Cancer Treatment and Research (13 papers), Peptidase Inhibition and Analysis (12 papers), Medical Imaging and Pathology Studies (10 papers), Neuroscience and Neuropharmacology Research (9 papers) and Amino Acid Enzymes and Metabolism (8 papers). The work is most often cited by research in Biochemistry (175 citations), Radiology, Nuclear Medicine and Imaging (499 citations) and Health, Toxicology and Mutagenesis (285 citations). Lin Zhu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Hank F. Kung, Xiaoshan Zhu, Karl Plöessl, Shengyan Tian, Yongsheng Chen, Zhenghua Duan, Yan Li, Zhihao Zha, Seok Choi and Brian P. Lieberman. Their work appears in journals such as Science, Journal of the American Chemical Society and Chemical Society Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.